Fannie Mae, Freddie Mac shares tumble after conservatorship comments
Investing.com - UBS maintained its Buy rating and $17.00 price target on Chemours (NYSE:CC), following an event with the company’s Advanced Performance Materials segment president and datacenter cooling venture head. Currently trading at $11.45, the stock shows potential upside according to InvestingPro Fair Value metrics, with analyst targets ranging from $11 to $20.
UBS analyst Joshua Spector highlighted Chemours’ development of two-phase immersion coolant and two-phase direct-to-chip coolant technologies, which could be essential for efficiently cooling advanced AI datacenters while reducing energy and water consumption in challenging geographic locations.
The financial impact from the datacenter opportunity is expected to materialize more significantly in 2027 and beyond, though UBS believes progress updates and commercialization milestones over the next 18 months could drive increased investor interest in the stock.
In the near to medium term, UBS maintains its Buy rating based on expectations of a titanium dioxide (TiO2) market inflection, including market share recovery from Chinese competitors, along with growing adoption of next-generation Opteon refrigerants.
Cost-saving initiatives at Chemours are also expected to contribute to higher growth over the next three years, with a significant performance improvement anticipated in 2026.
In other recent news, The Chemours Company has adjusted its second-quarter earnings guidance due to operational disruptions at its U.S. titanium dioxide facilities, now expecting adjusted EBITDA between $215 million and $225 million, below the Wall Street consensus of $236 million. Despite this guidance cut, Truist Securities maintained a buy rating, citing strong performance in the Thermal & Specialized Solutions division driven by demand for Opteon products. Chemours raised its second-quarter 2025 outlook, projecting mid-teens sequential growth in consolidated net sales and positive free cash flow, bolstered by robust demand in its refrigerant business and cost improvements in the advanced materials segment. The company’s Thermal & Specialized Solutions segment anticipates approximately 25% sequential growth in net sales, while the Advanced Performance Materials segment expects a 25% sequential increase in adjusted EBITDA. However, the Titanium Technologies segment faces a 15% decline in adjusted EBITDA due to a rail line service interruption, leading to higher costs. Chemours also announced the appointment of Matthew Conti as Chief Human Resources Officer and Nathan Blom as Vice President of its liquid cooling portfolio, moves aimed at strengthening its leadership team and strategic growth areas. These leadership changes are part of Chemours’ broader efforts to enhance its market position and address customer challenges with innovative solutions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.